Infobionic
Search
  • Products
    • MoMe ARC®
    • MoMe Sensors
    • MoMe Solutions
    • MoMe Gateway®
  • What We Solve
    • Arrhythmia Detection
    • Virtual Care Delivery
    • Hospital-to-Home
    • Value-Based Care
    • Health Equity and Access
    • Preventative Care
  • Who We Serve
    • Cardiology Practices
    • Cardiologists and EPs
    • Medical Leaders
    • Information Technology
    • Other Roles
  • Our Story
    • About
    • Customers
    • Leadership Team
    • Board of Directors
    • Strategic Advisory Board
  • Resources
    • Resource Center
    • Blog
    • Press Releases
    • In the News
    • Events
  • Contact

Is AI Transforming Cardiology? With Stuart Long, CEO of InfoBionic.Ai

October 10, 2024 | Stuart Long 0 Minute Read
Share Post
Medical Ai Podcast

Don’t miss a beat.
Receive updates from our blog.




    You Might Also Like:

    Infobionic Blogheader 112024 2 Patient Experience

    Stress, Cardiac Risk, and How to Manage: Practical Tips for Individuals...

    November 26, 2024 | Stuart Long

    7 Minute Read

    Radio Show Logos Uncategorized

    InfoBionic.Ai CEO Stuart Long Interviewed for U.K. Vascular Awareness Month

    November 14, 2024 | Dave MacCutcheon

    2 Second Read

    Infobionic Swirl Texture Full

    Discover the possibilities with the MoMe ARC®.

    TellMe More
    Infobionic Logo Vertical White

    321 Billerica Road
    OfficeLink #5
    Chelmsford, MA 01824

    • Products
    • What We Solve
    • Who We Serve
    • Our Story
    • Resources
    • Contact

    978.674.8304 | info@infobionic.ai

    © 2024 InfoBionic.Ai, All rights reserved

    InfoBionic.Ai’s MoMe® System may be covered under one or more of the following United States Patents: 8,478,418; 8,620,418; 8,744,561; 8,774,932; 8,798,734; 9,081,884; 9,307,914; 9,307,922; 9,968,274; 10,796,552; 10,595,737; 10,376,172; 10,332,379; 10,327,657; 10,297,132; 10,282,963 and 16/409,951. This website is provided to satisfy the virtual patent marking provisions of various jurisdictions including the America Invents Act and 35 U.S.C. § 287(a). Additional patents may be issued or pending in the US and elsewhere.

    Gsa Schedule
    Anab Accredited